Neutralizing antibodies isolated from COVID-19 patients may suppress virus

Researchers at Columbia University Irving Medical Center have isolated antibodies from several COVID-19 patients that, to date, are among the most potent in neutralizing the SARS-CoV-2 virus. These antibodies could be produced in large quantities by pharmaceutical companies to treat patients, especially early in the course of infection, and to prevent infection, particularly in the elderly.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news